Trials
Search / Trial NCT06420050

Testing a Novel Instagram Intervention for Heavy Alcohol Use

Launched by EMILY GREKIN · May 14, 2024

Apply for Trial

Trial Information

Current as of March 12, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Ages 18-30
  • • Report regular Instagram usage (i.e., at least a few times a week)
  • • Report having met the NIAAA's criteria for a binge-drinking episode (4+ drinks in a sitting for cisgender women, 5+ drinks in a sitting for all other genders) at least twice a month for the past three month
  • Exclusion Criteria:
  • • No exclusion criteria

About Emily Grekin

Emily Grekin is a dedicated clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a strong background in clinical operations and regulatory affairs, she leads initiatives that prioritize ethical standards and scientific rigor. Under her guidance, trials are meticulously designed and executed, ensuring adherence to regulatory guidelines while fostering innovation in therapeutic development. Emily's collaborative approach promotes strong partnerships with research institutions and stakeholders, ultimately driving the successful translation of clinical findings into real-world applications.

Locations

Detroit, Michigan, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0